Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

June 2005

Volume 1051 Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders

Pages xiii–xiv, 1–810

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Foreword (pages xiii–xiv)

      YEHUDA SHOENFELD and M. ERIC GERSHWIN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.200

  2. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis (pages 1–11)

      ANDRÉ P. van ROSSUM, PIETER C. LIMBURG and CEES G. M. KALLENBERG

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.041

    2. Clinical Relevance of Antiphospholipid Antibodies in Primary Biliary Cirrhosis (pages 20–28)

      PHILIPP von LANDENBERG, MICHAEL BAUMGARTNER, JUERGEN SCHOELMERICH, KARL J. LACKNER and REINHILD KLEIN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.043

    3. Crohn's Disease Is Associated with Polymorphism of CARD15/NOD2 Gene in a Hungarian Population (pages 45–51)

      ZSUZSANNA NAGY, OSZKÁR KARÁDI, GYÖRGY RUMI, GYÖRGY RUMI JR., ALAJOS PÁR, GYULA MÓZSIK, LÁSZLÓ CZIRJÁK and GÁBOR SÜT?

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.045

    4. Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy (pages 52–63)

      ESTHER REEFMAN, PIETER C. LIMBURG, CEES G. M. KALLENBERG and MARC BIJL

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.046

    5. Cancer-Associated Myositis: Clinical Features and Prognostic Signs (pages 64–71)

      ANDREA PONYI, TAMÁS CONSTANTIN, MIKLÓS GARAMI, CSILLA ANDRÁS, BÉLA TÁLLAI, ANDREA VÁNCSA, LAJOS GERGELY and KATALIN DANKÓ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.047

    6. Control of Type 1 Autoimmune Diabetes by Naturally Occurring CD4+CD25+ Regulatory T Lymphocytes in Neonatal NOD Mice (pages 72–87)

      C. A. PICCIRILLO, M. TRITT, E. SGOUROUDIS, A. ALBANESE, M. PYZIK and V. HAY

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.048

  3. Article: Part I. Organ-Specific Autoimmune Diseases

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Autoantibodies to Human α6 Integrin in Patients with Bullous Pemphigoid (pages 104–110)

      MÁRIA KISS, ÁDÁM PERÉNYI, ILONA MARCZINOVITS, JÁNOS MOLNÁR, ATTILA DOBOZY, LAJOS KEMÉNY and SÁNDOR HUSZ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.051

  4. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Soluble HLA Class I and Class II Molecules in Relapsing-Remitting Multiple Sclerosis: Acute Response to Interferon-β1a Treatment and Their Use as Markers of Disease Activity (pages 111–120)

      ALIREZA MINAGAR, IRENA ADAMASHVILLI, STEPHEN L. JAFFE, MICHAEL F. GLABUS, EDUARDO GONZALEZ-TOLEDO and ROGER E. KELLEY

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.052

    2. Proinflammatory Cytokines and Autoimmunity in Churg-Strauss Syndrome (pages 121–131)

      B. HELLMICH, E. CSERNOK and W. L. GROSS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.053

    3. Rheumatic Fever: How S. pyogenes-Primed Peripheral T Cells Trigger Heart Valve Lesions (pages 132–140)

      L. GUILHERME, K. C. FAÉ, S. E. OSHIRO, A. C. TANAKA, P M A POMERANTZEFF and J. KALIL

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.054

    4. Avidity of Anti-β2-Glycoprotein I and Thrombosis or Pregnancy Loss in Patients with Antiphospholipid Syndrome (pages 141–147)

      S. ČUČNIK, B. BOŽIČ, T. KVEDER, M. TOMŠIČ and B. ROZMAN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.055

    5. Neurological Complications of Celiac Disease and Autoimmune Mechanisms: Preliminary Data of a Prospective Study in Adult Patients (pages 148–155)

      C. BRIANI, G. ZARA, E. TOFFANIN, S. RUGGERO, A. FERRARINI, F. DE LAZZARI, M. LUCA, D. FAGGIAN, F. GRASSIVARO, M. ERMANI, R. PEZZANI, B. GIOMETTO and A. D'ODORICO

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.056

    6. E2F1−/− C57BL/6 Mice Overexpressing a Human Bcl-2 Transgene in B Cells Develop a Mild Autoimmune Syndrome (pages 156–165)

      MARÍA J. MARÍN, ITXASO GARCÍA, MARTA PEÑA, AINHOA BOLÍVAR, ANA ZUBIAGA and MARCOS LÓEZ-HOYOS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.057

    7. Systemic Thromboembolism in Inflammatory Bowel Disease: Mechanisms and Clinical Applications (pages 166–173)

      GILAD TWIG, GISELE ZANDMAN-GODDARD, MARTINE SZYPER-KRAVITZ and YEHUDA SHOENFELD

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.058

    8. Pregnancy Loss and Endometriosis: Pathogenic Role of Anti-Laminin-1 Autoantibodies (pages 174–184)

      JUNKO INAGAKI, AKANE KONDO, LUIS R. LOPEZ, YEHUDA SHOENFELD and EIJI MATSUURA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.059

    9. Primary Biliary Cirrhosis: Solving the Enigma (pages 185–193)

      ALESSIA GIORGINI, CARLO SELMI, PIETRO INVERNIZZI, M.URO PODDA, M.SSIMO ZUIN and M.ERIC GERSHWIN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.060

    10. The Stages of Type 1A Diabetes (pages 194–204)

      NARU BABAYA, MAKI NAKAYAMA and GEORGE S. EISENBARTH

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.061

    11. Soluble CD40L in Plasma of Patients with Primary Biliary Cirrhosis (pages 205–210)

      SABINE OERTELT, PIETRO INVERNIZZI, CARLO SELMI, M. URO PODDA and M. ERIC GERSHWIN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.062

    12. Decreased Serum Leptin Levels in Primary Biliary Cirrhosis: A Link between Metabolism and Autoimmunity? (pages 211–217)

      ROMAN RIEGER, SABINE OERTELT, CARLO SELMI, PIETRO INVERNIZZI, M.URO PODDA and M.ERIC GERSHWIN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.124

    13. Analysis of the Foxp3/Scurfin Gene in Crohn's Disease (pages 218–228)

      OGYI PARK, IRINA GRISHINA, PATRICK S. LEUNG, M. ERIC GERSHWIN and T. PRINDIVILLE

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.125

  5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Juvenile Systemic Sclerosis: A Follow-up Study of Eight Patients (pages 229–234)

      SZILVIA SZAMOSI, LÁSZLÓ MARÓDI, LÁSZLÓ CZIRJÁK, ZOLTÁN ELLENES and GABRIELLA SZÜCS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.063

    2. Generation and Characterization of Three Monoclonal IgM Antiphospholipid Antibodies Recognizing Different Phospholipid Antigens (pages 240–254)

      CATHARINA BUSCHMANN, CHRISTIAN FISCHER, VIOLA OCHSENHIRT, CAROLIN NEUKIRCH, KARL J. LACKNER and PHILIPP von LANDENBERG

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.065

    3. Premature Immunosenescence in Rheumatoid Arthritis and Multiple Sclerosis Patients (pages 255–262)

      MARIELLE THEWISSEN, LOES LINSEN, VEERLE SOMERS, PIET GEUSENS, JEF RAUS and PIET STINISSEN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.066

    4. Association of Rheumatoid Arthritis with HLA-DR1 and HLA-DR4 in Hungary (pages 263–270)

      ANIKÓ KAPITÁNY, ERIKA ZILAHI, SÁNDOR SZÁNTÓ, GABRIELLA SZÜCS, ZOLTÁN SZABÓ, ANIKÓ VÉGVÁRI, PÉTER RASS, SÁNDOR SIPKA, GYULA SZEGEDI and ZOLTÁN SZEKANECZ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.067

    5. Plasminogen Activator Inhibitor-1 Is Associated with Impaired Endothelial Function in Women with Systemic Lupus Erythematosus (pages 271–280)

      EMILY C. SOMERS, WENDY MARDER, MARIANA J. KAPLAN, ROBERT D. BROOK and W JOSEPH McCUNE

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.068

    6. Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media (pages 281–290)

      ROBERTO GERLI, Y.NIV SHERER, GAETANO VAUDO, GIUSEPPE SCHILLACI, BORIS GILBURD, ANDREA GIORDANO, ELENA BARTOLONI BOCCI, ROSITA ALLEGRUCCI, SIMONA MARCHESI, ELMO MANNARINO and Y.HUDA SHOENFELD

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.069

    7. Investigation of Arthritic Joint Destruction by a Novel Fibroblast-Based Model (pages 291–298)

      U. SACK, B. SEHM, F. KAHLENBERG, A. MURR, J. LEHMANN, A. TANNAPFEL, K. UBERLA, A. MOESSNER, A. DIETRICH, F. EMMRICH, F. LANGE, A. JUNGEL, J-M BRAUN and U. ANDEREGG

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.070

    8. Prevalence of Antiphospholipid and Antioxidized Low-Density Lipoprotein Antibodies in Rheumatoid Arthritis (pages 299–303)

      Y.NIV SHERER, ROBERTO GERLI, GAETANO VAUDO, GIUSEPPE SCHILLACI, BORIS GILBURD, ANDREA GIORDANO, ELENA BARTOLONI BOCCI, ROSITA ALLEGRUCCI, SIMONA MARCHESI, ELMO MANNARINO and Y.HUDA SHOENFELD

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.071

    9. Mono-organic versus Multi-organic Involvement in Primary Antiphospholipid Syndrome (pages 304–312)

      GABRIELA MEDINA, OLGA VERA-LASTRA, ULISES ANGELES and LUIS J. JARA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.072

    10. Systemic Lupus Erythematosus, Atherosclerosis, and Autoantibodies (pages 351–361)

      SANDRA ZAMPIERI, LUCA IACCARINO, ANNA GHIRARDELLO, ELENA TARRICONE, SILVIA ARIENTI, PIERCARLO SARZI-PUTTINI, PIERFRANCA GAMBARI and ANDREA DORIA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.077

    11. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases (pages 362–371)

      KARINA de LEEUW, CEES KALLENBERG and MARC BIJL

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.078

    12. Nocturnal Hormones and Clinical Rhythms in Rheumatoid Arthritis (pages 372–381)

      MAURIZIO CUTOLO, KATI OTSA, OIVI AAKRE and ALBERTO SULLI

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.079

    13. Humoral Antigenic Targets of the Ribosomal P0 Lupus Autoantigen Are Not Limited to the Carboxyl Region (pages 390–403)

      BENJAMIN F. BRUNER, DONNY M. WYNN, MORRIS REICHLIN, JOHN B. HARLEY and JUDITH A. JAMES

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.081

    14. Clinical Correlations of Potential Activity Markers in Systemic Sclerosis (pages 404–412)

      R. BEČVÁŘ, J. ŠTORK, V. PEŠÁKOVÁ, A. STÁŇOVÁ, H. HULEJOVÁ, L. RYSOVÁ, A. ZATLOUKALOVÁ, P. ZATLOUKAL, M. JÁCHYMOVÁ and L. POUROVÁ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.082

    15. Complement Activation: A Novel Pathogenic Mechanism in the Antiphospholipid Syndrome (pages 413–420)

      SILVIA S. PIERANGELI, MARIANO VEGA-OSTERTAG, XIAOWEI LIU and GUILLERMINA GIRARDI

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.083

    16. The Interplay of Chemokines and Dendritic Cells in the Pathogenesis of Lupus Nephritis (pages 421–432)

      MARCO TUCCI, NICOLA CALVANI, HANNO B. RICHARDS, COSIMA QUATRARO and FRANCO SILVESTRIS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.084

    17. Cellular and Molecular Mechanisms of Regulation of Autoantibody Production in Lupus (pages 433–441)

      BEVRA H. HAHN, FANNY EBLING, RAM R. SINGH, RAM P. SINGH, GEORGE KARPOUZAS and ANTONIO LA CAVA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.085

    18. The Role of Innate and Adaptive Immunity to Oxidized Low-Density Lipoprotein in the Development of Atherosclerosis (pages 442–454)

      KAZUKO KOBAYASHI, LUIS R. LOPEZ, YEHUDA SHOENFELD and EIJI MATSUURA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.086

    19. Predictive Markers for Development of Severe Organ Involvement in Patients with Systemic Sclerosis (pages 455–464)

      LAURE YSEBRANT de LENDONCK, ANNICK OCMANT, FLORENCE ROUFOSSE and ELIE COGAN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.087

    20. Hughes Syndrome, the Antiphospholipid Syndrome: A New Chapter in Neurology (pages 465–486)

      GIOVANNI SANNA, MARIA LAURA BERTOLACCINI and GRAHAM R. V. HUGHES

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.088

    21. New Facet of Antiphospholipid Antibodies (pages 487–497)

      GUIDO VALESINI and CRISTIANO ALESSANDRI

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.089

  6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment

    1. Top of page
    2. Frontmatter
    3. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    4. Article: Part I. Organ-Specific Autoimmune Diseases
    5. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part I. Organ-Specific Autoimmune Diseases
    6. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part II. Systematic Autoimmune Diseases
    7. Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders: Part III. Treatment
    1. Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates (pages 498–505)

      CH von AUER, J. OLDENBURG, M. von DEPKA, C. ESCURIOLA-ETTINGHAUSEN, K. KURNIK, H. LENK and I. SCHARRER

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.094

    2. Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab (pages 506–514)

      E. TOUBI, A. KESSEL, Z. MAHMUDOV, K. HALLAS, M. ROZENBAUM and I. ROSNER

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.095

    3. Synergistic Effect of Avemar on Proinflammatory Cytokine Production and Ras-Mediated Cell Activation (pages 515–528)

      ANDRÁS TELEKES, ENDRE KISS-TÓTH, TÜNDE NAGY, EVA E. QWARNSTROM, ERZSÉBET KÚSZ, TIMEA POLGÁR, ÁKOS RESETÁR, STEVEN K. DOWER and ERN? DUDA

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.096

    4. Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases (pages 529–542)

      LASZLO G. BOROS, MICHELE NICHELATTI and YEHUDA SHOENFELD

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.097

    5. Open-Label 24-Month Study Evaluating Infliximab Therapy in Patients with Psoriatic Spondyloarthropathy (pages 543–550)

      J. J. SCALI, A. KAMINSKY, J. SALOMÓN, S. VISENTINI and E. DANCZIGER

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.098

    6. Autoimmunity and Anti-TNF-α Agents (pages 559–569)

      FABIOLA ATZENI, MAURIZIO TURIEL, FRANCO CAPSONI, ANDREA DORIA, PIERLUIGI MERONI and PIERCARLO SARZI-PUTTINI

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.100

    7. Combination Treatment of Rat Adjuvant-Induced Arthritis with Methotrexate, Probiotic Bacteria Enterococcus faecium, and Selenium (pages 570–581)

      JOZEF ROVENSKÝ, KAROL ŠVÍK, VLADIMÍR MA?HA, RICHARD IŠTOK, VOJTĚCH KAMARÁD, LIBOR EBRINGER, MIROSLAV FERENČÍK and MÁRIA STANČÍKOVÁ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.101

    8. Comparative Analysis of Antigen Specificities in the Monomeric and Dimeric Fractions of Intravenous Immunoglobulin (pages 582–590)

      SYLVIA M. MIESCHER, ALEXANDER SCHAUB, MARCO GHIELMETTI, MICHAEL BAUMANN, MONIQUE VOGEL, REINHARD BOLLI and BEDA STADLER

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.102

    9. Treatment of Pemphigus Vulgaris with Protein A Immunoadsorption: Case Report of Long-Term History Showing Favorable Outcome (pages 591–596)

      NINA FROST, GERALD MESSER, GERHARD FIERLBECK, TEUT RISLER and SIMON D. LYTTON

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.103

    10. Immunosuppressive Therapy and Clinical Evolution in Forty-nine Patients with Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis (pages 597–605)

      E. KOKOLINA, E. ALEXOPOULOS, C. DIMITRIADIS, A. VAINAS, P. GIAMALIS, A. PAPAGIANNI, D. EKONOMIDOU and D. MEMMOS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.104

    11. Removal of Pathogenic Autoantibodies by Immunoadsorption (pages 635–646)

      ALON Y. HERSHKO and YAAKOV NAPARSTEK

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.108

    12. Rationale for T Cell Inhibition by Cyclosporin A in Major Autoimmune Diseases (pages 658–665)

      G.F FERRACCIOLI, P. TOMIETTO and M. DE SANTIS

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.110

    13. Partial Response to Anti-CD20 Monoclonal Antibody Treatment of Severe Immune Thrombocytopenic Purpura in a Patient with Common Variable Immunodeficiency (pages 666–671)

      J. CARBONE, A. ESCUDERO, M. MAYAYO, M. BALLESTEROS, A. PEREZ-CORRAL, S. SANCHEZ-RAMON, E. SARMIENTO, D. MICHELOUD and E. FERNANDEZ-CRUZ

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.111

    14. CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases (pages 672–683)

      FEDERICO PEROSA, ELVIRA FAVOINO, MARIA ANTONIETTA CARAGNANO and FRANCO DAMMACCO

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.112

    15. Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines (pages 716–729)

      JOCHEN ZWERINA, KURT REDLICH, GEORG SCHETT and JOSEF S. SMOLEN

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.116

    16. Anti-inflammatory and Immune Regulatory Properties of 5-Androsten-3β, 17β-Diol (HE2100), and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases (pages 730–742)

      D. AUCI, F. NICOLETTI, K. MANGANO, R. PIETERS, S. NIERKENS, L. MORGAN, H. OFFNER, J. FRINCKE and C. READING

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.117

    17. Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin (pages 779–786)

      YAIR LEVY, YOSEF UZIEL, GIESELE ZANDMAN, PNINA ROTMAN, HAWARED AMITAL, YANIV SHERER, PNINA LANGEVITZ, BOLECK GOLDMAN and YEHUDA SHOENFELD

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.121

      Corrected by:

      Corrigendum for Ann. N.Y. Acad. Sci. 2005. 1051: 779–786

      Vol. 1270, Issue 1, 120, Version of Record online: 10 OCT 2012

    18. Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases (pages 787–798)

      HELENA TLASKALOVÁ-HOGENOVÁ, LUDMILA TUCKOVÁ, RENATA STEPÁNKOVÁ, TOMÁS HUDCOVIC, LENKA PALOVÁ-JELÍNKOVÁ, HANA KOZÁKOVÁ, PAVEL ROSSMANN, DANIEL SANCHEZ, JANA CINOVÁ, TOMÁS HRNČÍŘ, MILOSLAV KVERKA, LENKA FROLOVÁ, HOLM UHLIG, FIONA POWRIE and PAUL BLAND

      Version of Record online: 9 JAN 2006 | DOI: 10.1196/annals.1361.122

SEARCH

SEARCH BY CITATION